BioAge Labs (BIOA) Research & Development (2023 - 2026)

BioAge Labs has disclosed Research & Development across 4 years of filings, most recently posting $20.4 million for Q1 2026.

• Research & Development for Q1 2026 came in at $20.4 million, up 83.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $83.3 million (up 36.9% YoY), and the FY2025 annual result was $74.0 million, up 25.29% from the prior year.
• Research & Development came in at $20.4 million for Q1 2026 at BioAge Labs, down from $24.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.5 million in Q4 2025 to a low of $6.5 million in Q3 2023.
• The 4-year median for Research & Development is $18.5 million (2025), against an average of $15.5 million.
• Across the five-year window, Research & Development jumped 206.48% in 2024 and slipped 7.52% in 2025, its largest moves.
• BioAge Labs' Research & Development stood at $10.1 million in 2023, then jumped by 90.69% to $19.2 million in 2024, then grew by 27.44% to $24.5 million in 2025, then slipped by 16.69% to $20.4 million in 2026.
• The last three Research & Development figures came in at $20.4 million (Q1 2026), $24.5 million (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.